Skip to content

A Comparative Study Of Raktaposhak Vati and Yograj Rasayana in the management of Anaemia

A Comparative Study Of Raktaposhak Vati and Yograj Rasayana in the management of Tridoshaja Pandu Vyadhi (vis-a-vis Iron deficiency Anemia)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007504
Enrollment
100
Registered
2016-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having Tridoshaja Pandu ( Iron deficiency Anemia)

Interventions

Intervention1: Yograj Rasayana vati: Yograj Rasayana vati will be given in comparative with Raktaposhak vati Intervention2: YOGRAJA RASAYANA VATI: a comparative study of Raktaposhaka vati and Yograja

Sponsors

Maharashtra Arogya Mandal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Tridoshaja pandu vyadhi will be diagnosed according to subjective and objective parameters 2)Hb% : more than 6 gm and less than normal 3) Patients will be selected irrespective of gender, religion, socio-ecomical status

Exclusion criteria

Exclusion criteria: 1)Bleeding disorders, hemorrhoids, menorrhagia 2)Pregnancy and lactation 3)K/C/O endocrine disorders and Tuberculosis, Leprosy, Carcinoma etc. 4)Patients with severe anemia (Hb% less than 6 gms) 5) Patients suffering from thalassemias, sickle cell anemia, spherocytosis etc. 6) Acute life threatening condition

Design outcomes

Primary

MeasureTime frame
Study the effect of Raktaposhak vati and Yograja Rasayana Vati on clinical symptoms and haematological parameters of Tridoshaja Pandu Vyadhi. Timepoint: The drugs will be given for 2 months. The patients will be assessed before and after the treatment. The total study period is 12 months.

Secondary

MeasureTime frame
Study the effect of Raktaposhak vati and Yograja Rasayana Vati on clinical symptoms and haematological parameters of Tridoshaja Pandu Vyadhi.Timepoint: The drugs will be given for 2 months. The patients will be assessed before and after the treatment. The total study period is 12 months.

Countries

India

Contacts

Public ContactDr Yogesh Tukaram Kotangale

Maharashtra Arogya Mandal

drytk@yahoo.com9423218193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026